Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Prevention of bone loss with tibolone in postmenopausal women: results of two randomized, double-blind, placebo-controlled, dose-finding studies.

Gallagher JC, Baylink DJ, Freeman R, McClung M.

J Clin Endocrinol Metab. 2001 Oct;86(10):4717-26.

PMID:
11600531
2.

[Postmenopausal hormonal treatment: conventional hormone replacement therapy or tibolone? Effects on bone].

Reginster JY.

J Gynecol Obstet Biol Reprod (Paris). 2002 Oct;31(6):541-9. Review. French.

3.

Tibolone and its effects on bone: a review.

Berning B, Bennink HJ, Fauser BC.

Climacteric. 2001 Jun;4(2):120-36. Review.

PMID:
11428176
4.

Strontium ranelate for preventing and treating postmenopausal osteoporosis.

O'Donnell S, Cranney A, Wells GA, Adachi JD, Reginster JY.

Cochrane Database Syst Rev. 2006 Jul 19;(3):CD005326. Review. Update in: Cochrane Database Syst Rev. 2006;(4):CD005326.

PMID:
16856092
5.

Tibolone for postmenopausal women: systematic review of randomized trials.

Modelska K, Cummings S.

J Clin Endocrinol Metab. 2002 Jan;87(1):16-23. Review. No abstract available.

PMID:
11788614
6.

Tibolone decreases Lipoprotein(a) levels in postmenopausal women: A systematic review and meta-analysis of 12 studies with 1009 patients.

Kotani K, Sahebkar A, Serban C, Andrica F, Toth PP, Jones SR, Kostner K, Blaha MJ, Martin S, Rysz J, Glasser S, Ray KK, Watts GF, Mikhailidis DP, Banach M; Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group.

Atherosclerosis. 2015 Sep;242(1):87-96. doi: 10.1016/j.atherosclerosis.2015.06.056. Epub 2015 Jul 2. Review.

PMID:
26186655
7.

Tibolone and breast cancer.

Erel CT, Senturk LM, Kaleli S.

Postgrad Med J. 2006 Oct;82(972):658-62. Review.

Supplemental Content

Support Center